1. Home
  2. IMNM vs HOG Comparison

IMNM vs HOG Comparison

Compare IMNM & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

N/A

Current Price

$19.53

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Logo Harley-Davidson Inc.

HOG

Harley-Davidson Inc.

N/A

Current Price

$26.89

Market Cap

2.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNM
HOG
Founded
2006
1903
Country
United States
United States
Employees
N/A
6400
Industry
Medicinal Chemicals and Botanical Products
Motor Vehicles
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.9B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
IMNM
HOG
Price
$19.53
$26.89
Analyst Decision
Strong Buy
Buy
Analyst Count
16
15
Target Price
★ $35.20
$27.90
AVG Volume (30 Days)
1.3M
★ 1.9M
Earning Date
11-05-2026
11-03-2026
Dividend Yield
N/A
★ 2.80%
EPS Growth
★ 51.40
N/A
EPS
N/A
★ 0.97
Revenue
$6,941,000.00
★ $4,473,175,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,747.97
$3.81
P/E Ratio
★ N/A
$27.58
Revenue Growth
N/A
★ N/A
52 Week Low
$13.53
$17.09
52 Week High
$30.06
$28.86

Technical Indicators

Market Signals
Indicator
IMNM
HOG
Relative Strength Index (RSI) 30.12 54.99
Support Level $19.39 $26.22
Resistance Level $23.48 $28.76
Average True Range (ATR) 1.12 0.85
MACD -0.27 0.21
Stochastic Oscillator 13.81 78.88

Price Performance

Historical Comparison
IMNM
HOG

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.

Share on Social Networks: